期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
促红细胞生成素对高糖诱导大鼠近端肾小管上皮细胞转分化的影响 被引量:1
1
作者 张锦华 高明 +1 位作者 朱小静 李立立 《陕西医学杂志》 CAS 2022年第10期1183-1186,1200,共5页
目的:研究促红细胞生成素(EPO)对高糖诱导的大鼠近端肾小管上皮细胞(NRK52E)转分化(EMT)的影响及其分子机制。方法:在25 mmol/L浓度葡萄糖培养基中培养NRK52E,建立高糖诱导的肾小管上皮细胞EMT模型。实验分为正常对照组(NC组)、甘露醇... 目的:研究促红细胞生成素(EPO)对高糖诱导的大鼠近端肾小管上皮细胞(NRK52E)转分化(EMT)的影响及其分子机制。方法:在25 mmol/L浓度葡萄糖培养基中培养NRK52E,建立高糖诱导的肾小管上皮细胞EMT模型。实验分为正常对照组(NC组)、甘露醇对照组(OC组)、高葡萄糖浓度组(HG组)、HG+EPO 50 U/ml组(E1组)以及HG+EPO 100 U/ml组(E2组)。其中NC组培养在正常环境中,OC组培养在19.5 mmol/L甘露醇环境中,其余三组培养在高糖环境中,且E1、E2组按要求添加相应浓度的EPO。RT-PCR检测促红素受体(EPOR)、E钙粘蛋白(E-cadherin)及α平滑肌肌动蛋白(α-SMA) mRNA的表达,Western blot检测EPOR、E-cadherin及α-SMA蛋白表达;荧光探针检测胞内活性氧(ROS)水平。结果:高糖培养成功诱导NRK52E细胞EMT模型,相较于NC组,HG组细胞EPOR、α-SMA表达增加,E-cadherin表达降低,细胞ROS水平显著增加(均P<0.05);EPO干预抑制NRK52E细胞EMT,与HG组比较,E1和E2组E-cadherin表达增加,α-SMA表达降低,细胞内ROS水平降低,且E2组变化更显著。结论:EPO可能通过EPO受体的介导,缓解高糖诱导的氧化应激,抑制高糖诱导的大鼠近端肾小管上皮细胞表型转化。 展开更多
关键词 糖尿病肾病 细胞生成 促红素受体 近端肾小管上皮细胞 上皮间充质转分化 氧化应激
下载PDF
miR-141的过表达抑制MHCC-97H肝癌细胞的增殖和侵袭迁移 被引量:3
2
作者 姚博文 薛雨墨 +3 位作者 刘志奎 徐蒙 涂康生 王军 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2016年第8期1083-1087,1093,共6页
目的观察肝细胞癌组织中miR-141的表达水平,通过上调MHCC-97H肝癌细胞中miR-141的水平观察对MHCC-97H细胞增殖、侵袭及迁移的影响。方法实时定量PCR检测miR-141在肝癌及癌旁组织中的表达水平,并分析miR-141表达水平与临床病理指标的关... 目的观察肝细胞癌组织中miR-141的表达水平,通过上调MHCC-97H肝癌细胞中miR-141的水平观察对MHCC-97H细胞增殖、侵袭及迁移的影响。方法实时定量PCR检测miR-141在肝癌及癌旁组织中的表达水平,并分析miR-141表达水平与临床病理指标的关系及生存率。利用人工合成的miR-141模拟物,瞬时转染MHCC-97H细胞。MTT法检测MHCC-97H细胞的增殖,TranswellTM实验检测MHCC-97H细胞的侵袭及迁移,Westernblot法及免疫组织化学检测miR-141下游潜在靶点肝细胞产生的促红素受体A2(EphA2)的表达。结果miR-141在肝癌组织中表达水平显著低于相应癌旁组织;肝癌组织中miR-141低表达与TNM分期、门静脉侵犯及Edmondson分级显著相关;低表达miR-141患者3年生存率明显低于高表达组;miR-141模拟物转染可上调MHCC-97H细胞miR-141水平,上调miR-141可显著抑制MHCC-97H细胞的增殖、侵袭及迁移,并下调EphA2的蛋白水平;miR-141低表达组EphA2蛋白水平明显高于miR-141高表达组,相关性分析显示肝癌组织中miR-141与EphA2蛋白表达呈显著负相关。结论miR-141在肝癌组织中表达下调且与EphA2表达呈显著负相关,其低表达与肝癌恶性临床病理特征有关,上调miR-141表达可抑制EphA2的表达抑制肝癌细胞增殖、侵袭及迁移能力。 展开更多
关键词 miR-141 肝细胞癌 增殖 侵袭 迁移 肝细胞产生的促红素受体A2(EphA2)
下载PDF
Erythropoietin -induced proliferation of gastric mucosal cells 被引量:3
3
作者 Kazuro Itoh Yoshio Sawasaki +10 位作者 Kyoko Takeuchi Shingo Kato Nobuhiro Imai Yoichiro Kato Noriyuki Shibata Makio Kobayashi Yoshiyuki Moriguchi Masato Higuchi Fumio Ishihata Yushi Sudoh Soichiro Miura 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第2期234-239,共6页
AIM: To analyze the localization of erythropoietin receptor on gastric specimens and characterize the effects of erythropoietin on the normal gastric epithelial proliferation using a porcine gastric epithelial cell c... AIM: To analyze the localization of erythropoietin receptor on gastric specimens and characterize the effects of erythropoietin on the normal gastric epithelial proliferation using a porcine gastric epithelial cell culture model. METHODS: Erythropoietin receptor was detected by RT-PCR, Western blotting and immunohistochermistry. Growth stimulation effects of erythropoietin on cultured gastric mucosal cells were determined by ELISA using bromodeoxyuridine (BrdU). RESULTS: Erythropoietin receptor was detected on cultured porcine gastric mucosal epithelial cells. Erythropoietin receptor was also detected histochemically at the base of gastric mucosal epithelium. BrdU assay demonstrated a dose-dependent increase in growth potential of cultured porcine gastric mucosal epithelial cells by administration of erythropoietin, as well as these effects were inhibited by administration of antierythropoietin antibody (P〈 0.01). CONCLUSION: These findings indicate that erythropoietin has a potential to proliferate gastric mucosal epithelium via erythropoietin receptor. 展开更多
关键词 ERYTHROPOIETIN Erythropoietin receptor Gastric epithelial cell proliferation Porcine gastric mucosal epithelial cells
下载PDF
Functional significance of erythropoietin receptor on tumor cells 被引量:3
4
作者 Kodetthoor B Udupa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第46期7460-7462,共3页
Erythropoietin (Epo) is the regulator of red blood cell formation. Its receptor (EpoR) is now found in many cells and tissues of the body. EpoR is also shown to occur in tumor cells and Epo enhances the proliferation ... Erythropoietin (Epo) is the regulator of red blood cell formation. Its receptor (EpoR) is now found in many cells and tissues of the body. EpoR is also shown to occur in tumor cells and Epo enhances the proliferation of these cells through cell signaling. EpoR antagonist can reduce the growth of the tumor in vivo. In view of our current knowledge of Epo, its recombinant forms and receptor, use of Epo in cancer patients to enhance the recovery of hematocrit after chemotherapy treatment has to be carefully evaluated. 展开更多
关键词 ERYTHROPOIETIN Tumor cell RECEPTOR Cell signaling PROLIFERATION Erythroid cell
下载PDF
IMMUNOHISTOCHEMICAL DISTRIBUTION OF ERYTHROPOIETIN AND ITS RECEPTOR EXPRESSION IN POSTNATAL RAT RETINA DEVELOPMENT
5
作者 钟一声 刘小红 +1 位作者 黄萍 程瑜 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2008年第2期102-108,共7页
Objective To investigate the distribution of erythropoietin (EPO) and erythropoietin receptor ( EPOR ) expression in the postnatal rat retina development. Methods Forty-two male Sprague-Dawley rats were divided in... Objective To investigate the distribution of erythropoietin (EPO) and erythropoietin receptor ( EPOR ) expression in the postnatal rat retina development. Methods Forty-two male Sprague-Dawley rats were divided into 7 groups according to their various postnatal days: postnatal 1 d (D1 group), 3 d (D3 group), I week (W1 group), 2 weeks (W2 group), 3 weeks (W3 group), 4 weeks (W4 group) and8 weeks (W8 group) ( n = 6 ). Single eye was randomly chosen from each rat for the study. The retinal sections were stained with hematoxylin and eosin (HE) and used for the retina development observation. Immunohistochemical staining was used to localize EPO and EPOR expressions in retinas.of differentstages of development, and the expression intensities were determined by an image plus 4 program~~ Results The retinal inner nuclear layer (INL) and outer nuclear layer (ONL) were mixed together and had not yet fully differentiated in D1 and D3 groups. The INL and ONL formed their own independent regions and the outer plexiform layer (OPL) appeared between two layers in W1 group. With the postnatal retinal development, the inner plexiform layer ( IPL ) , rods and cones layer ( RCL ), and OPL were gradually widened and stabilized in W2 to W3 groups. EPO/EPOR expressions located prominently in the inner part of the postnatal rat developing retinas. The expression of EPO in GCL and INL gradually increased from DI to W4, then the expression decreased in W8. Expression of EPOR in GCL gradually increased from DI to WI , then decreased in W2 ; and it gradually increased again from W3 to W8. Expression of EPOR in INL gradually increased from D1 to W1, then decreased in W2 ; and it continued to decrease from W3 to W8. Expression of EPOR in the external segment of RCL gradually increased from D1 to W8. However, expression in the internal segment of RCL gradually decreased from D1 to W3 , then no obvious expression was seen in the internal segment of RCL in W4 and W8. Conclusion EPO/EPOR expressions locate prominently in the inner part of the postnatal rat developing retina. And EPO/EPOR expressions in the rat retinas exist the dynamic changes during the postnatal retina development period. 展开更多
关键词 erythropoietin erythropoietin receptor retina development immunohistochemistry rat
下载PDF
Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma 被引量:3
6
作者 Lin Wang Hai-Gang Li +2 位作者 Zhong-Sheng Xia Jian-Ming Wen Jun Lv 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第34期3933-3940,共8页
AIM: To investigate the expression of Erythropoietin (Epo) and its receptor (EpoR) in gastric adenocarcinoma (GAC) and the correlation with angiogenesis and clinicopathological features. METHODS: The expressions of Ep... AIM: To investigate the expression of Erythropoietin (Epo) and its receptor (EpoR) in gastric adenocarcinoma (GAC) and the correlation with angiogenesis and clinicopathological features. METHODS: The expressions of Epo, EpoR and vascular endothelial growth factor (VEGF), as well as mi-crovessel density were evaluated in 172 GAC biopsies by immunohistochemical staining. The correlations between these parameters and patient’s clinicopathological features were analyzed statistically. RESULTS: The proportion of Epo and EpoR alterations in GAC was higher than that in adjacent normal mucosa (P = 0.035 and 0.030). Epo high-expression was associ-ated with EpoR high-expression, Lauren type, extensivelymph node metastasis and advanced stage of GAC (P = 0.018, 0.018, 0.004 and 0), while EpoR expression was linked with older age, World Health Organization type, extensive lymph node metastasis and advanced stage (P = 0.001, 0.013, 0.008 and 0.001). VEGF high expression was significantly correlated with EpoR low-expression, Lauren type, extensive lymph node metastasis and advanced stage (P = 0.001, 0.001, 0.001 and 0.007). The expression of Epo or EpoR was associated with microvessel density (P = 0.004 and 0.046). On multivariate analysis, only lymph node metastasis, abnormal Epo expression and tumor nodes metastases stage were independently associated with survival. In addition, a strong association with the immunohistochemical expression of EpoR and the angiogenic protein, VEGF, was noted. CONCLUSION: Increased expression of Epo and EpoR may play a signif icant role in the carcinogenesis, angiogenesis and progression of GAC. Epo may be an inde-pendent prognostic factor. 展开更多
关键词 Erythropoietin Erythropoietin receptor Gas- tric adenocarcinoma Immunohistochemistry Prognosis
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部